News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation
- Melatonin and cancer From the promotion of genomic stability to use in cancer treatment
- International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
- Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair
- The nuclear receptor RXRA controls cellular senescence by regulating calcium signaling
- Melatonin and pancreatic cancer: Current knowledge and future perspectives
- Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity
- Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor
- Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma
- Differential Potentiation of Retinoic Acid Effects against Human Breast Cancer Cells by Unsaturated Fatty Acids
- Over-Expression of GH/GHR in Breast Cancer and Oncosuppressor Role of Somatostatin as a Physiological Inhibitor (from Di Bella's Foundation)
- Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients
- Affinity purification and structural characterization of a specific binding protein for human growth hormone in human serum
- The somatomedin hypothesis: 2001
- Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: A case report
- Adjuvant chemotherapy with melatonin for targeting human cancers: A review
- Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
- Over-Expression of GH/GHR in Breast Cancer and Oncosuppressor Role of Somatostatin as a Physiological Inhibitor
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- About melatonin - 1996
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Frequently Asked Questions
- Vademecum
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways